Multiple SkleroseMS BehandlungNeuroimmunologie

2023

Shinoda K, Li R, Rezk A, Mexhitaj I, Patterson KR, Kakara M, Zuroff L, Bennett JL, von Büdingen HC, Carruthers R, Edwards KR, Fallis R, Giacomini PS, Greenberg BM, Hafler DA, Ionete C, Kaunzner UW, Lock CB, Longbrake EE, Pardo G, Piehl F, Weber MS, Ziemssen T, Jacobs D, Gelfand JM, Cross AH, Cameron B, Musch B, Winger RC, Jia X, Harp CT, Herman A, Bar-Or A.

Proc Natl Acad Sci U S A. 2023 Jan 17;120(3):e2207291120.

Multiple SkleroseMS Behandlung

2022

Ziemssen T, Groth M, Ettle B, Bopp T.

Vaccines (Basel). 2022 Dec 16;10(12):2167.

Multiple SkleroseMS Behandlung

2022

Inojosa H, Proschmann U, Akgün K, Ziemssen T.

Ther Adv Chronic Dis 2022;13.

Multiple SkleroseMS Behandlung

2022

Koeditz D, Frensch J, Bierbaum M, Ness NH, Ettle B, Vudumula U, Gudala K, Adlard N, Tiwari S, Ziemssen T.

Mult Scler J Exp Transl Clin. 2022 Mar 29;8(1):20552173221085741.

Multiple SkleroseMS Behandlung

2022

Constantinescu V, Akgün K, Ziemssen T.

Expert Opin Drug Metab Toxicol 2022;18(10):675-693.

Multiple SkleroseMS Behandlung

2022

Butzkueven H, Giacomini PS, Cohan S, Ziemssen T, Sienkiewicz D, Zhang Y, Geissbühler Y, Silva D, Tomic D, Kropshofer H, Trojano M.

Brain Sci. 2022 Feb 4;12(2):215.

Multiple SkleroseMS Behandlung

2022

Comi G, Dadon Y, Sasson N, Steinerman JR, Knappertz V, Vollmer TL, Boyko A, Vermersch P, Ziemssen T, Montalban X, Lublin FD, Rocca MA, Volkinshtein R, Rubinchick S, Halevy N, Filippi M.

Mult Scler. 2022 Apr;28(4):608-619.

Multiple SkleroseMS Behandlung

2022

Coles AJ, Jones JL, Vermersch P, Traboulsee A, Bass AD, Boster A, Chan A, Comi G, Fernández Ó, Giovannoni G, Kubala Havrdova E, LaGanke C, Montalban X, Oreja-Guevara C, Piehl F, Wiendl H, Ziemssen T.

Mult Scler. 2022 Apr;28(5):842-846.